• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by QT Imaging Holdings Inc.

    11/14/24 4:01:08 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $QTI alert in real time by email
    SC 13G 1 form_sc13g_qtimagingholdings.htm


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. )*

    QT Imaging Holdings, Inc.
    (Name of Issuer)

    Common Stock, par value $0.0001 per share
    (Title of Class of Securities)

    746962109
    (CUSIP Number)

    September 30, 2024
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)
    ☐ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    CUSIP No.: 746962109
     
     
     
     
    1
    NAME OF REPORTING PERSON
    Lynrock Lake LP
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐
    (b) ☐
    3
    SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
    1,920,721
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    1,920,721
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,920,721
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    9.0% (1)
    12
    TYPE OF REPORTING PERSON
    PN, IA
    (1) Based on 21,441,416 shares of Common Stock of QT Imaging Holdings, Inc. (the “Issuer”) outstanding as of September 20, 2024, as reported in the Issuer's Prospectus Supplement filed with the Securities and Exchange Commission (“SEC”) on September 20, 2024.

    CUSIP No.: 746962109
     
     
     
     
    1
    NAME OF REPORTING PERSON
    Lynrock Lake Partners LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐
    (b) ☐
    3
    SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
    1,920,721
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    1,920,721
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,920,721
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    9.0% (1)
    12
    TYPE OF REPORTING PERSON
    OO, HC
    (1) Based on 21,441,416 shares of Common Stock of the Issuer outstanding as of September 20, 2024, as reported in the Issuer's Prospectus Supplement filed with the SEC on September 20, 2024.

    CUSIP No.: 746962109
     
     
     
     
    1
    NAME OF REPORTING PERSON
    Cynthia Paul
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐
    (b) ☐
    3
    SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
    1,920,721
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    1,920,721
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,920,721
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    9.0% (1)
    12
    TYPE OF REPORTING PERSON
    IN, HC
    (1) Based on 21,441,416 shares of Common Stock of the Issuer outstanding as of September 20, 2024, as reported in the Issuer's Prospectus Supplement filed with the SEC on September 20, 2024.

    CUSIP No.: 746962109
     
     
     
    ITEM 1(a).
    NAME OF ISSUER:
     
     
     
    QT Imaging Holdings, Inc. (the “Issuer”)
     
     
    ITEM 1(b).
    ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
     
     
     
    3 Hamilton Landing, Suite 160
    Novato, CA 94949
     
     
    ITEM 2(a).
    NAME OF PERSON FILING:
     
     
     
    Lynrock Lake LP
    Lynrock Lake Partners LLC
    Cynthia Paul
     
     
    ITEM 2(b).
    ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
     
     
     
    2 International Drive, Suite 130
    Rye Brook, NY 10573
     
     
    ITEM 2(c).
    CITIZENSHIP:
     
     
     
    Lynrock Lake LP - Delaware
    Lynrock Lake Partners LLC - Delaware
    Cynthia Paul - United States
     
     
    ITEM 2(d).
    TITLE OF CLASS OF SECURITIES:
     
     
     
    Common Stock, par value $0.0001 per share (“Common Stock”)
     
     
    ITEM 2(e).
    CUSIP NUMBER:
     
     
     
    746962109

    ITEM 3.
    IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A:
     
     
     
    (a) ☐ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c);
     
     
     
    (b) ☐ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
     
     
     
    (c) ☐ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
     
     
     
    (d) ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
     
     
     
    (e) ☒ An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
     
     
     
    (f) ☐ An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
     
     
     
    (g) ☒ A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
     
     
     
    (h) ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
     
     
    (i) ☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
     
     
    (j) ☐ A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);
     
     
     
    (k) ☐ Group, in accordance with 240.13d-1(b)(1)(ii)(K).
     
     
    ITEM 4.
    OWNERSHIP:
     
     
     
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
     
     
     
     
    (a)
    Amount beneficially owned as of September 30, 2024:
     
     
    Lynrock Lake LP - 1,920,721
    Lynrock Lake Partners LLC - 1,920,721
    Cynthia Paul - 1,920,721
     
     
     
     
    (b)
    Percent of class as of September 30, 2024:
     
     
    Lynrock Lake LP - 9.0%
    Lynrock Lake Partners LLC - 9.0%
    Cynthia Paul - 9.0%
     
     
     
     
    (c)
         Number of shares as to which the person has:
     
     
     
     
     
    (i) Sole power to vote or to direct the vote:
     
     
    Lynrock Lake LP - 1,920,721
    Lynrock Lake Partners LLC - 1,920,721
    Cynthia Paul - 1,920,721
     
     
     
     
     
    (ii) Shared power to vote or to direct the vote:
     
     
    Lynrock Lake LP - 0
    Lynrock Lake Partners LLC - 0
    Cynthia Paul - 0
     
     
     
     
     
    (iii) Sole power to dispose or to direct the disposition of:
     
     
    Lynrock Lake LP - 1,920,721
    Lynrock Lake Partners LLC - 1,920,721
    Cynthia Paul - 1,920,721
     
       
     
     
    (iv) Shared power to dispose or to direct the disposition of:
     
     
    Lynrock Lake LP - 0
    Lynrock Lake Partners LLC - 0
    Cynthia Paul - 0

    As of September 30, 2024, Lynrock Lake Master Fund LP (“Lynrock Lake Master”) directly held 1,920,721 shares of the Issuer's Common Stock. In addition, as of September 30, 2024, Lynrock Lake Master directly held warrants of the Issuer that are not presently exercisable into shares of the Issuer's Common Stock due to a 4.9% beneficial ownership limitation. Lynrock Lake LP (the “Investment Manager”) is the investment manager of Lynrock Lake Master, and pursuant to an investment management agreement, the Investment Manager has been delegated full voting and investment power over securities of the Issuer held by Lynrock Lake Master. Cynthia Paul, the Chief Investment Officer of the Investment Manager and Sole Member of Lynrock Lake Partners LLC, the general partner of the Investment Manager, may be deemed to exercise voting and investment power over securities of the Issuer held by Lynrock Lake Master.

    ITEM 5.
    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
     
     
     
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.
     
     
    ITEM 6.
    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
     
     
     
    As disclosed in Item 4 of this Schedule 13G, as of September 30, 2024, Lynrock Lake Master directly held 1,920,721 shares of the Issuer's Common Stock. Certain feeder funds that invest in Lynrock Lake Master may have the right to receive dividends from, or the proceeds from the sale of, the securities directly held by Lynrock Lake Master.
     
     
    ITEM 7.
    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
     
     
     
    Not applicable.
     
     
    ITEM 8.
    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
     
     
     
    Not applicable.
       
    ITEM 9.
    NOTICE OF DISSOLUTION OF GROUP:
     
     
     
    Not applicable.
     
     
    ITEM 10.
    CERTIFICATION:
     
     
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: November 14, 2024

    LYNROCK LAKE LP
    By: Lynrock Lake Partners LLC,
    its general partner
     
     
     
     
    By:
    /s/ Cynthia Paul
     
    Name:
    Cynthia Paul
     
    Title:
    Sole Member
     
     
     
     
     
     
     
    LYNROCK LAKE PARTNERS LLC
     
     
     
     
    By:
    /s/ Cynthia Paul
     
    Name:
    Cynthia Paul
     
    Title:
    Sole Member
     
     
     
     
    /s/ Cynthia Paul
     
     
    CYNTHIA PAUL
     


    EXHIBIT 99.1

    JOINT FILING AGREEMENT

    In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G, dated November 14, 2024 (including amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of QT Imaging Holdings, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments to such joint filing and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the other.


    LYNROCK LAKE LP
    By: Lynrock Lake Partners LLC,
    its general partner
     
     
     
     
    By:
    /s/ Cynthia Paul                                          
     
    Name:
    Cynthia Paul
     
    Title:
    Sole Member
     
     
     
     
     
     
     
    LYNROCK LAKE PARTNERS LLC
     
     
     
     
    By:
    /s/ Cynthia Paul
     
    Name:
    Cynthia Paul
     
    Title:
    Sole Member
     
     
     
     
    /s/ Cynthia Paul
     
     
    CYNTHIA PAUL
     



    Get the next $QTI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QTI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $QTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Greene James S bought $250,000 worth of shares (428,082 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:04:44 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Dickson Daniel H bought $50,000 worth of shares (85,616 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:54 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chairman Katz Avi S bought $1,834,999 worth of shares (3,142,122 units at $0.58), increasing direct ownership by 252% to 657,960 units (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:30 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Greene James S bought $250,000 worth of shares (428,082 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:04:44 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Dickson Daniel H bought $50,000 worth of shares (85,616 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:54 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chairman Katz Avi S bought $1,834,999 worth of shares (3,142,122 units at $0.58), increasing direct ownership by 252% to 657,960 units (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:30 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    QT Imaging Receives FDA Clearance for Its Breast Acoustic CT Scanner Enhanced Configuration to Improve Posterior Breast Imaging Coverage

    QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for an updated configuration of its Breast Acoustic CT™ scanner, the Company's 3D ultrasound tomographic breast imaging system. The newly cleared enhanced configuration improves visualization and expands coverage of posterior breast tissue. "The updated configuration cleared by the FDA incorporates a tilted transmitter geometry that improves tomographic imaging coverage of breast tissue located near the che

    3/10/26 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Names Renowned Breast Cancer Researcher Dr. Mary Yamashita as Medical Advisor

    QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that Mary W. Yamashita, MD will serve as Medical Advisor to the Company. In her role as QT Imaging Medical Advisor, Dr. Yamashita will provide strategic advisory and development support across several key areas, including clinical interpretation standards, structured reporting frameworks, training architecture, and reader study design. Her expertise will be instrumental in optimizing clinical integration and user experience, ensuring that the Company's technologies not only

    3/4/26 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Achieves Major Reimbursement Milestone with AMA Category III CPT Code for 3D Breast Ultrasound Tomography

    The Company's first CPT code becomes effective January 1, 2027, enables billing and opening new commercial opportunities with hospital accounts QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that the American Medical Association (AMA) CPT (Current Procedural Terminology) Editorial Panel has approved a new Category III CPTTM code for 3D quantitative transmission volumetric ultrasound tomography of the breast. The new Category III code, X579T, represents a significant milestone in the clinical and commercial advancement

    2/23/26 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    SEC Filings

    View All

    QT Imaging Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

    2/25/26 4:06:30 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

    2/18/26 8:41:05 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SCHEDULE 13G filed by QT Imaging Holdings Inc.

    SCHEDULE 13G - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    2/17/26 4:48:41 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Leadership Updates

    Live Leadership Updates

    View All

    QT Imaging Announces First Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $1.4M with 56% Gross Margin in the First Quarter of 2024, Since the Company Became Public on March 4th Streamlined Business Model via Strategic Sales and Distribution Partnership in USA Reported in Academic Radiology the Results of a Second Blinded Screening Trial That Found That QTI Technology Is Similarly Effective as Digital Breast Tomosynthesis (DBT) or 3D Mammography Company Completed Merger with GigCapital5 QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first qu

    5/10/24 8:57:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Financials

    Live finance-specific insights

    View All

    QT Imaging Reports Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

    Generated Record Revenue of $8.3 Million in Q4 2025, up 97% versus Q3 2025 Shipped Record 17 Scanners in Q4 2025 and 40 in 2025, up from 12 Scanners Shipped in 2024 Exceeded 2025 Sales Outlook, Delivering Revenue of $18.9 Million Relisted on Nasdaq Less Than One Year After Leaving the Exchange Continues to Pivot from a Scanner Company to a SaaS and Biomarker-Driven Medical Imaging Franchise QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company") a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announces preliminary unaudited financial results for the fourth quarter and full year

    2/18/26 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Announces Third Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $0.9 Million with 65% Gross Margin in the Third Quarter of 2024 The Company Successfully Completed the Engineering and Clinical Feasibility Study with its Strategic Partner The Company Announced Entering into Favorable Amendments to Its $10 Million Convertible Promissory Note with YA II PN, Ltd. The Company Announced Insiders PIPE investment of $2.56 Million, fully funded by the QTI Board of Directors members and their Affiliates QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results

    11/13/24 8:32:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Announces Second Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $1.7 Million with 51% Gross Margin in the Second Quarter of 2024 The Company Continues to Make Progress in the Engineering and Clinical Feasibility Study with its Strategic Partner Signed a U.S. Exclusive Distribution Agreement Announced Partnership with the University of Oklahoma and OU Health Stephenson Cancer Center to Improve Precision in Cancer Detection and Treatment QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the second quarter of 2024. "QT Imaging's team comp

    8/8/24 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by QT Imaging Holdings Inc.

    SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    11/22/24 4:15:11 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by QT Imaging Holdings Inc.

    SC 13G - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    11/14/24 4:01:08 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by QT Imaging Holdings Inc.

    SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    9/13/24 4:23:43 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care